Fortress Biotech, Inc. (FBIO)
1.92
-0.08
(-4.00%)
USD |
NASDAQ |
Oct 30, 16:00
1.92
0.00 (0.00%)
After-Hours: 17:36
Fortress Biotech Cash and Short Term Investments (Annual) : 79.38M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 79.38M |
| December 31, 2024 | 57.26M |
| December 31, 2023 | 80.93M |
| December 31, 2022 | 178.27M |
| December 31, 2021 | 305.74M |
| December 31, 2020 | 233.35M |
| December 31, 2019 | 136.86M |
| December 31, 2018 | 83.11M |
| December 31, 2017 | 130.95M |
| Date | Value |
|---|---|
| December 31, 2016 | 91.68M |
| December 31, 2015 | 98.18M |
| December 31, 2014 | 69.76M |
| December 31, 2013 | 99.52M |
| December 31, 2012 | 40.20M |
| December 31, 2011 | 23.16M |
| December 31, 2010 | 14.86M |
| December 31, 2009 | 1.51M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Kura Oncology, Inc. | 667.24M |
| Spero Therapeutics, Inc. | 40.26M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |